Credit Suisse’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-59,200
Closed -$1.19M 4368
2020
Q4
$1.19M Buy
+59,200
New +$1.24M ﹤0.01% 3217
2019
Q1
Sell
-472,000
Closed -$9.28M 4017
2018
Q4
$9.28M Buy
472,000
+442,000
+1,473% +$7.88M 0.01% 1193
2018
Q3
$532K Buy
+30,000
New +$585K ﹤0.01% 3260
2016
Q4
Sell
-101,600
Closed -$1.3M 4122
2016
Q3
$1.3M Buy
+101,600
New +$1.1M ﹤0.01% 2738

Other funds holding EXEL

Credit Suisse's EXEL Position: Q1 2024 in Review

Credit Suisse increased its Exelixis (EXEL) stake by 2.1% in Q1 2024, buying an estimated $160K and bringing the position to 352,756 shares worth $8.37M. The position accounts for 0.01% of the portfolio, ranked #1006.

Credit Suisse first reported a position in EXEL in Q2 2013 and has held it in 44 quarters since. The position peaked at $23.6M in Q4 2017. 423 funds tracked by Wall St. Rank hold EXEL as of Q1 2024.

  • Credit Suisse held 352,756 shares of Exelixis worth $8.37M as of Q1 2024.
  • Credit Suisse bought 7,204 Exelixis shares in Q1 2024, an estimated $160K.
  • Exelixis made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1006 holding.
  • Credit Suisse first reported a position in Exelixis in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Exelixis position peaked at $23.6M in Q4 2017.
  • 423 funds tracked by Wall St. Rank held Exelixis as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.